S. 3716 (119th)Congressional Activities
A bill to set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions.
Health|Health
Sponsor
Cosponsors
Support
Democratic
Introduced
Jan 28, 2026
Discussions
Current stageCommittee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced
Committee
Floor
President
Law
Congressional Activities
This tab collects committee work, CRS research, hearings, and amendment activity as those sources become available for the bill.
No congressional activity records are linked to this bill yet.